- Home
- RCON vs WGSWW Comparison
RCON vs WGSWW Comparison
Compare RCON & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- WGSWW
- Stock Information
- Founded
- RCON 2007
- WGSWW 2017
- Country
- RCON China
- WGSWW United States
- Employees
- RCON N/A
- WGSWW N/A
- Industry
- RCON Oilfield Services/Equipment
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- RCON Energy
- WGSWW Technology
- Exchange
- RCON Nasdaq
- WGSWW Nasdaq
- Market Cap
- RCON N/A
- WGSWW N/A
- IPO Year
- RCON 2009
- WGSWW N/A
- Fundamental
- Price
- RCON $1.83
- WGSWW $0.17
- Analyst Decision
- RCON
- WGSWW
- Analyst Count
- RCON 0
- WGSWW 0
- Target Price
- RCON N/A
- WGSWW N/A
- AVG Volume (30 Days)
- RCON 9.0K
- WGSWW 36.6K
- Earning Date
- RCON 01-01-0001
- WGSWW 02-18-2025
- Dividend Yield
- RCON N/A
- WGSWW N/A
- EPS Growth
- RCON N/A
- WGSWW N/A
- EPS
- RCON N/A
- WGSWW N/A
- Revenue
- RCON $8,996,572.00
- WGSWW $305,450,000.00
- Revenue This Year
- RCON N/A
- WGSWW N/A
- Revenue Next Year
- RCON $15.18
- WGSWW N/A
- P/E Ratio
- RCON N/A
- WGSWW N/A
- Revenue Growth
- RCON 2.59
- WGSWW 50.79
- 52 Week Low
- RCON $1.26
- WGSWW $0.17
- 52 Week High
- RCON $3.70
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- RCON 58.73
- WGSWW N/A
- Support Level
- RCON $1.44
- WGSWW N/A
- Resistance Level
- RCON $1.67
- WGSWW N/A
- Average True Range (ATR)
- RCON 0.15
- WGSWW 0.00
- MACD
- RCON 0.04
- WGSWW 0.00
- Stochastic Oscillator
- RCON 84.31
- WGSWW 0.00
Stock Price Comparison Chart: RCON vs WGSWW
■ RCON
■ WGSWW
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
Share on Social Networks:
0